Richard A Proctor
Overview
Explore the profile of Richard A Proctor including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
92
Citations
4037
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Proctor R, Jackson A, Fowler V
Vaccine
. 2025 Mar;
53:126896.
PMID: 40048962
Development of a vaccine against Staphylococcus aureus has proven to be difficult, in no small measure due to our lack of understanding of the human immune response to this pathogen....
2.
Ersoy S, Rose W, Proctor R
Antibiotics (Basel)
. 2025 Jan;
14(1).
PMID: 39858381
Since its standardization, clinical antimicrobial susceptibility testing (AST) has relied upon a standard medium, Mueller-Hinton Broth/Agar (MHB/A), to determine antibiotic resistance. However, this microbiologic medium bears little resemblance to the...
3.
Saito M, McDonald K, Grier A, Grier A, Meghwani H, Rangel-Moreno J, et al.
bioRxiv
. 2025 Jan;
PMID: 39803468
prosthetic joint infections (PJIs) are broadly considered incurable, and clinical diagnostics that guide conservative vs. aggressive surgical treatments don't exist. Multi-omics studies in a humanized NSG-SGM3 BLT mouse model demonstrate...
4.
Li Y, Mishra N, Chen L, Manna A, Cheung A, Proctor R, et al.
J Infect Dis
. 2024 Dec;
PMID: 39739874
Background: Methicillin-resistant Staphylococcus aureus (MRSA) is a leading pathogen causing severe endovascular infections. The prophage-encoded protein Gp05 has been identified as a critical virulence factor that contributes to MRSA persistence...
5.
Ersoy S, Madrigal S, Proctor R, Chambers H, Xiong Y, Bayer A
J Antimicrob Chemother
. 2024 Dec;
80(3):676-681.
PMID: 39704154
Background: Methicillin-resistant Staphylococcus aureus (MRSA) are resistant to nearly all β-lactam antibiotics under standard testing conditions. However, a novel phenotype exists wherein certain MRSA strains exhibit β-lactam susceptibility in the...
6.
Ersoy S, Madrigal S, Chen L, Mediavilla J, Kreiswirth B, Flores E, et al.
Clin Microbiol Infect
. 2024 Dec;
PMID: 39626860
Objectives: The objective of this study is to assess the frequency of the novel sodium bicarbonate (NaHCO)-responsive phenotype, wherein clinical methicillin-resistant Staphylococcus aureus (MRSA) isolates are rendered susceptible to standard-of-care...
7.
Volk C, Proctor R, Rose W
Int J Mol Sci
. 2024 Jun;
25(12).
PMID: 38928191
bacteremia continues to be associated with significant morbidity and mortality, despite improvements in diagnostics and management. Persistent infections pose a major challenge to clinicians and have been consistently shown to...
8.
Dogan E, Sydow K, Heiden S, Eger E, Wassilew G, Proctor R, et al.
Front Cell Infect Microbiol
. 2024 Apr;
14:1372704.
PMID: 38601740
In this study, we characterized a strain in a patient with shrapnel hip injury, which resulted in multiple phenotypic changes, including the formation of a small colony variant (SCV) phenotype....
9.
Ersoy S, Proctor R, Rose W, Abdelhady W, Fan S, Madrigal S, et al.
Antimicrob Agents Chemother
. 2024 Feb;
68(3):e0162723.
PMID: 38349162
Methicillin-resistant (MRSA) strains are a major challenge for clinicians due, in part, to their resistance to most β-lactams, the first-line treatment for methicillin-susceptible . A phenotype termed "NaHCO-responsiveness" has been...
10.
Chan L, Lee H, Wang L, Chaili S, Xiong Y, Bayer A, et al.
Antibiotics (Basel)
. 2023 Jul;
12(7).
PMID: 37508276
Invasive methicillin-resistant (MRSA) infections are leading causes of morbidity and mortality that are complicated by increasing resistance to conventional antibiotics. Thus, minimizing virulence and enhancing antibiotic efficacy against MRSA is...